Hyperkalemia Mechanism - Heparin

With lower aldosterone levels, the kidneys reabsorb less sodium and secrete less potassium into the urine, leading to potassium retention in the bloodstream. Timeline and Susceptibility Heparin-induced hyperkalemia - PubMed

Heparin-induced hyperkalemia is an under-recognized but common metabolic complication occurring in about treated with heparin. The primary mechanism is a direct suppression of aldosterone production in the adrenal glands, which impairs the kidneys' ability to excrete potassium . Pathophysiological Mechanism heparin hyperkalemia mechanism

Heparin is thought to inhibit 18-hydroxylase , a key enzyme in the final stages of aldosterone steroidogenesis. With lower aldosterone levels, the kidneys reabsorb less

Heparin, a widely used anticoagulant, is known for its efficacy in preventing and treating thrombotic disorders. However, one of its lesser-known side effects is its potential to induce hyperkalemia, a condition characterized by elevated potassium levels in the blood. In this blog post, we will delve into the mechanism behind heparin-induced hyperkalemia, its risk factors, and strategies for prevention and management. In this blog post, we will delve into

: Heparin (and its low-molecular-weight derivatives) directly inhibits the zona glomerulosa of the adrenal cortex. This reduces the activity of enzymes critical for aldosterone production, particularly the conversion of corticosterone to 18-hydroxycorticosterone and then to aldosterone.

Some evidence suggests heparin may have a direct toxic effect on the adrenal zona glomerulosa cells, leading to physical narrowing of this adrenal layer over prolonged use.